You are here

CurePSP Ask the Doctor #4 - July 7, 2020

CurePSP Ask the Doctor #4 - July 7, 2020

CurePSP-Ask-Doc-July-2020.png

Have a question about living with progressive supranuclear palsy (PSP), multiple system atrophy (MSA), or corticobasal degeneration (CBD)?

Have a question about living with progressive supranuclear palsy (PSP), multiple system atrophy (MSA), or corticobasal degeneration (CBD)? Lawrence I. Golbe, M.D., CurePSP's director of clinical affairs, will provide answers during the next “Ask the Doctor” webinar on Tuesday, July 7, 2020, at 4:00 p.m. Eastern Daylight Time (1:00 p.m. Pacific).

Dr. Globe will address questions that are submitted during registration by patients and families. You also can email your questions to info@curepsp.org.

The webinar will be set up on Zoom Video Communications. Registration is required. This webinar will be recorded and emailed out in the following days to all registrants.

Know that Dr. Golbe cannot give any case-specific medical advice, however, he will cover information that may answer your questions. Any medications that are referred to during the webinar should not be tried unless under the supervision of a licensed professional.

Joanna Teters, CurePSP’s community outreach and education coordinator, will serve as moderator.

Those who register will receive a link to the webinar twice from Eventbrite before the event: (1) one hour before the event and (2) ten minutes before. If you do not see these emails in your inbox, please check your spam/junk folder.

Watch The Replay

Dr. Golbe, Emeritus Professor of Neurology at Rutgers Robert Wood Johnson Medical School in New Brunswick, NJ., is a leading clinical expert in PSP and related neurodegenerative conditions. He is the author of "A Clinician’s Guide to Progressive Supranuclear Palsy."

He graduated from Brown University and New York University School of Medicine and did residency training at NYU/Bellevue before assuming his current position in 1983. He was Acting Chair of his department from 2000 to 2003 and was Program Director of its neurology residency from 2003 to 2018. His research is in the clinical genetics, clinimetrics, and epidemiology of parkinsonian disorders.

In 1988 Dr. Golbe co-led the first studies of the prevalence and risk factors in PSP. He led the clinical portion of the project that in 1997 identified the first known Mendelian mutation causing Parkinson’s disease in the gene for alpha-synuclein.

Dr. Golbe devised the PSP Rating Scale, which since its publication in 2007 has become the standard clinical measure and treatment outcome marker for PSP world-wide. He has a referral practice for patients with PSP and CBD, and he conducts multiple ongoing research studies.

He has worked closely with CurePSP since 1992, presently as Director of Clinical Affairs, chair of its Medical Advisory Board, and a member of its Board of Directors.

CurePSP is a nonprofit organization working to increase awareness, advocate for patients and families, and fund research for devastating prime of life neurodegenerative diseases, including PSP. This is the fourth "Ask the Doctor" webinar.

Watch the "Ask the Doctor" webinar from April 6, 2020, below:

Watch the "Ask the Doctor" webinar from May 5, 2020, below:

Watch the "Ask the Doctor" webinar from June 11, 2020, below: